2018, Oct. 29-31: VEROVACCiNES GmbH to present at the 18th Annual World Vaccine Congress, Lisbon, Portugal.

The current status of VEROVACCiNES multivalent subunit marker vaccine development will be presented by CEO Dr. Hanjo Hennemann at the 18th Annual World Vaccine Congress, Lisbon Portugal from 29-31 October 2018.
The World Veterinary Vaccine Congress brings animal health industry experts from the whole value chain under one roof to discuss scientific, regulatory and commercial issues from new innovative vaccine technologies to emerging disease.
Come and see us!